ARCHIVES

Federal AIDS Funds Tp $2 Bil.; Term Proposed For NIH Director

This article is from The Cancer Letter archive.

Vol. 16 No. 40 | October 19, 1990

Download PDF Visit The Full Archive

Related Articles

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

Genetic Test Identifies Patients With High Risk of Mortality

November 30, 2012

Interview: Extramural Programs Need Coordination, Klausner Says

July 25, 1997

HHS Forms Office for Recovery Act

March 13, 2009

First Phase 0 Oncology Trial Demonstrates Effectiveness Of New Drug On Its Target

April 24, 2009

Comprehensive Center NCAB Evaluations

June 2, 1978